NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Pursuing an Alternative to Cigarettes Using Proprietary Technology
Related Editorial In a country where the life-threatening risks of smoking are well-known and 22 million smokers want to quit, a milestone agreement between a drug delivery platform innovator and one of the world’s largest producers and marketers of tobacco and cigarettes may offer tobacco users an alternative method of satisfying their needs along with greatly reduced risk. The quest for other alternatives to cigarettes has brought Big Tobacco to the door of biotech company Lexaria. The bioscience potential for nicotine delivery cannot be ignored and may deliver myriad benefits. Lexaria’s proprietary DehydraTECH technology makes the company an ideal partner. Lexaria…







